Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47

United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$276.81M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$16.42M

$436.05K on a plan · $2.68M straight out of an exercise

Sold at will

$13.31M

22 of 47 sales

Net

+$260.39M

+$263.50M against sales at will